Suppr超能文献

术中阿片类药物对腹腔镜胃束带术后疼痛和肺功能的影响:瑞芬太尼靶控输注与舒芬太尼靶控输注用于病态肥胖患者的比较

Influence of intraoperative opioid on postoperative pain and pulmonary function after laparoscopic gastric banding: remifentanil TCI vs sufentanil TCI in morbid obesity.

作者信息

De Baerdemaeker L E C, Jacobs S, Pattyn P, Mortier E P, Struys M M R F

机构信息

Department of Anaesthesia, Ghent University Hospital, Ghent, Belgium.

出版信息

Br J Anaesth. 2007 Sep;99(3):404-11. doi: 10.1093/bja/aem164. Epub 2007 Jul 2.

Abstract

BACKGROUND

Choice of opioid may influence postoperative pain, recovery, and respiratory homeostasis in morbid obesity. The aim of this study was to compare the effects of target-controlled infusions (TCIs) of remifentanil or sufentanil on postoperative analgesia, recovery, and pulmonary function after laparoscopic gastric banding.

METHODS

Forty morbidly obese patients undergoing laparoscopic gastric banding received BIS-guided desflurane anaesthesia combined with remifentanil TCI (Group R) or sufentanil TCI (Group S). Intraoperative haemodynamic stability, BIS controllability, and immediate recovery in the operating room were measured. Pulmonary function, modified Aldrete score, modified Observers Assessment of Alertness and Sedation score, blood gas analysis, and visual analogue score for pain and postoperative nausea and vomiting were measured on admission to the post-anaesthesia care unit and 30, 60, 120 min afterwards. After operation, patients received patient-controlled analgesia with morphine.

RESULTS

During the first two postoperative hours, cumulative morphine consumption was higher in the remifentanil group compared with the sufentanil group, but was equal values after that time. Recovery profiles and spirometry showed no significant differences. During maintenance, remifentanil gave a better haemodynamic stability.

CONCLUSIONS

As few differences occurred in the postoperative period, the theoretical advantage of remifentanil over the longer acting sufentanil can be questioned when using TCI technology.

摘要

背景

在病态肥胖患者中,阿片类药物的选择可能会影响术后疼痛、恢复情况及呼吸稳态。本研究旨在比较瑞芬太尼或舒芬太尼靶控输注(TCI)对腹腔镜胃束带术后镇痛、恢复及肺功能的影响。

方法

40例接受腹腔镜胃束带手术的病态肥胖患者接受脑电双频指数(BIS)引导下的地氟醚麻醉,并联合瑞芬太尼TCI(R组)或舒芬太尼TCI(S组)。术中测量血流动力学稳定性、BIS可控性及在手术室的即刻恢复情况。在进入麻醉后护理单元时以及之后的30、60、120分钟测量肺功能、改良Aldrete评分、改良警觉与镇静观察评分、血气分析以及疼痛和术后恶心呕吐的视觉模拟评分。术后患者接受吗啡自控镇痛。

结果

术后前两小时,瑞芬太尼组累积吗啡用量高于舒芬太尼组,但此后两组用量相当。恢复情况及肺量计检查结果无显著差异。维持麻醉期间,瑞芬太尼的血流动力学稳定性更佳。

结论

由于术后差异较少,在使用TCI技术时,瑞芬太尼相较于作用时间更长的舒芬太尼的理论优势可能受到质疑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验